Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)
This study has been completed.
Sponsor:
Objectif Recherche Vaccins SIDA
Information provided by:
Objectif Recherche Vaccins SIDA
ClinicalTrials.gov Identifier:
NCT00219362
First received: September 16, 2005
Last updated: November 24, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2006 |
| Primary Completion Date: | November 2005 (Final data collection date for primary outcome measure) |